ARK Genomic Revolution ETF Newsroom

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500

Benzinga15:23 ET

Bernstein Maintains Outperform on Natera, Raises Price Target to $135

BenzingaOct 30 14:59 ET · Ratings

Natera Shares Are Trading Higher After Canaccord Genuity Maintained a Buy Rating on the Stock and Raised Its Price Target From $145 to $150.

BenzingaOct 29 13:41 ET

Looking Into Intellia Therapeutics's Recent Short Interest

BenzingaOct 29 09:45 ET

7 Analysts Have This To Say About Intellia Therapeutics

BenzingaOct 25 10:00 ET

Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

BenzingaOct 24 22:17 ET

Intellia Therapeutics Analyst Ratings

BenzingaOct 24 17:42 ET · Ratings

UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus

Seeking AlphaOct 24 15:32 ET

A Closer Look at Intellia Therapeutics's Options Market Dynamics

BenzingaOct 24 14:45 ET

Why Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday?

BenzingaOct 24 12:43 ET

3 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaOct 24 12:37 ET

Intellia Slips After Mid-stage Data for CRISPR-based Hereditary Angioedema Therapy

Seeking AlphaOct 24 09:14 ET

Twist Bioscience Analyst Ratings

BenzingaOct 17 10:55 ET · Ratings

Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock

BenzingaOct 16 23:19 ET

Veracyte Started at Buy by UBS, MRD Platform Cited

Seeking AlphaOct 16 14:29 ET

Natera Analyst Ratings

BenzingaOct 16 09:37 ET · Ratings

CareDx Analyst Ratings

BenzingaOct 16 09:30 ET · Ratings

Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views

BenzingaOct 15 11:57 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaOct 15 08:08 ET

Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

BenzingaOct 14 10:29 ET